0,893  0,002  Angiogenesis stimulant
0,861  0,008  Antiinflammatory
0,730  0,005  Atherosclerosis treatment
0,661  0,005  Antifungal
0,574  0,017  Immunosuppressant
0,578  0,023  Antibacterial
0,528  0,004  Pneumotoxic
0,548  0,025  Cholesterol antagonist
0,522  0,037  CYP3A4 substrate
0,476  0,018  Nitric oxide antagonist
0,437  0,005  DNA polymerase I inhibitor
0,456  0,027  NOS3 expression inhibitor
0,441  0,040  Antithrombotic
0,422  0,032  ICAM1 expression inhibitor
0,407  0,029  Cardiovascular analeptic
0,390  0,018  Abortion inducer
0,373  0,005  UGT2B9 substrate
0,399  0,045  Respiratory analeptic
0,440  0,086  Autoimmune disorders treatment
0,372  0,032  Antihypoxic
0,357  0,018  Contraceptive
0,358  0,021  UGT1A4 substrate
0,348  0,018  UGT2B7 substrate
0,394  0,069  Antipruritic, allergic
0,398  0,078  TNF expression inhibitor
0,362  0,047  Analeptic
0,371  0,058  Bone diseases treatment
0,315  0,004  Transcription factor NF kappa B stimulant
0,328  0,018  Antiacne
0,356  0,048  CTGF expression inhibitor
0,320  0,019  Antieczematic atopic
0,369  0,074  Ulceration
0,326  0,033  GST M1-1 substrate
0,337  0,048  UGT2B4 substrate
0,303  0,021  Antipruritic, non-allergic
0,346  0,067  Prostate cancer treatment
0,328  0,049  Sensitization
0,360  0,082  GST A substrate
0,304  0,031  UGT1A1 substrate
0,276  0,004  Neutropenia treatment
0,390  0,119  Apoptosis agonist
0,333  0,062  Antipsoriatic
0,351  0,080  CYP2C9 substrate
0,296  0,028  Antimigraine
0,319  0,061  Interleukin 2 agonist
0,267  0,009  UGT2B1 substrate
0,300  0,043  Antiparasitic
0,278  0,025  Lipocortins synthesis antagonist
0,338  0,086  Antileukemic
0,286  0,035  Antihelmintic
0,280  0,045  Chemopreventive
0,310  0,077  Hepatic disorders treatment
0,286  0,057  Proliferative diseases treatment
0,317  0,100  Antiasthmatic
0,223  0,007  Actinic keratosis treatment
0,269  0,053  Antiulcerative
0,225  0,009  Contraceptive male
0,243  0,028  Protein kinase stimulant
0,232  0,022  Antifungal enhancer
0,268  0,057  Cytotoxic
0,272  0,065  NOS2 expression inhibitor
0,292  0,087  AR expression inhibitor
0,291  0,087  Sodium/bile acid cotransporter inhibitor
0,296  0,096  Transcription factor NF kappa B inhibitor
0,218  0,019  Arachidonic acid antagonist
0,205  0,006  Vanilloid agonist
0,282  0,083  Metabolic disease treatment
0,263  0,065  Gastrin inhibitor
0,247  0,051  RNA-directed DNA polymerase inhibitor
0,231  0,036  UGT1A3 substrate
0,228  0,033  Interferon gamma antagonist
0,218  0,025  UGT2B10 substrate
0,264  0,075  UGT1A9 substrate
0,219  0,032  Toxic, respiratory center
0,205  0,019  Endometrios treatment
0,340  0,154  Caspase 9 stimulant
0,236  0,054  UDP-glucuronosyltransferase substrate
0,241  0,066  UGT1A6 substrate
0,197  0,021  Antifungal (Cryptococcus)
0,178  0,008  Anabolic
0,245  0,075  Antineoplastic (liver cancer)
0,203  0,035  Antirickettsial
0,246  0,085  5 Hydroxytryptamine uptake stimulant
0,231  0,071  Antihypotensive
0,276  0,126  Toll-Like receptor 7 agonist
0,175  0,026  Antineoplastic antibiotic
0,195  0,050  Acaricide
0,156  0,013  UGT2B11 substrate
0,228  0,085  Antineoplastic (cervical cancer)
0,192  0,050  Prostate disorders treatment
0,188  0,047  UGT2B15 substrate
0,168  0,029  Pregnane X receptor agonist
0,145  0,006  Narcotic antagonist
0,160  0,024  Ca2+-transporting ATPase inhibitor
0,268  0,133  Toll-Like receptor agonist
0,170  0,036  Cholesterol synthesis inhibitor
0,150  0,019  Antibiotic
0,202  0,073  Anesthetic general
0,221  0,093  Antihypercholesterolemic
0,157  0,029  Contraceptive female
0,136  0,011  Glycine receptor antagonist
0,180  0,058  ATPase inhibitor
0,147  0,034  Choleretic
0,127  0,016  3C-Like protease (SARS coronavirus) inhibitor
0,222  0,112  CYP2C19 substrate
0,142  0,035  GABA C receptor antagonist
0,134  0,027  Androgen antagonist
0,214  0,112  Tyrosine 3 hydroxylase inhibitor
0,119  0,017  Na+ K+ transporting ATPase inhibitor
0,235  0,135  Antineoplastic (lung cancer)
0,140  0,043  Microtubule formation inhibitor
0,099  0,004  Pregnane X receptor antagonist
0,153  0,058  Adenylate cyclase stimulant
0,123  0,029  Estrogen receptor beta antagonist
0,211  0,117  Antiosteoporotic
0,104  0,013  Androgen agonist
0,190  0,103  Antineoplastic (lymphoma)
0,234  0,147  FMO1 substrate
0,186  0,100  Antialcoholic
0,118  0,032  Antispirochetal
0,128  0,042  Estrogen antagonist
0,181  0,097  Neurotrophic factor enhancer
0,157  0,073  Melanin inhibitor
0,136  0,052  Skin irritative effect
0,108  0,030  ATPase (Vacuolar H+) inhibitor
0,095  0,018  Postmenopausal disorders treatment
0,124  0,047  GABA C receptor agonist
0,098  0,027  Leukotriene synthesis inhibitor
0,143  0,073  Hair growth stimulant
0,160  0,092  Carcinogenic
0,217  0,148  Antiallergic
0,087  0,021  Estrogen agonist
0,124  0,057  Constipation treatment
0,135  0,072  Bone formation stimulant
0,145  0,083  Restenosis treatment
0,194  0,133  DNA synthesis inhibitor
0,216  0,158  Vasodilator, peripheral
0,088  0,030  Glycine receptor agonist
0,116  0,060  SULT1A1 substrate
0,157  0,102  Hepatoprotectant
0,069  0,016  Estrogen receptor beta agonist
0,077  0,024  Andropause treatment
0,093  0,042  Opioid kappa receptor antagonist
0,134  0,084  Antimutagenic
0,078  0,028  SULT2A1 substrate
0,117  0,067  Menstruation disorders treatment
0,076  0,026  Antimycoplasmal
0,051  0,002  Granulocyte colony stimulating factor receptor agonist
0,081  0,032  Anticholelithogenic
0,070  0,021  Lipocortins synthesis agonist
0,118  0,069  Alcohol dehydrogenase substrate
0,163  0,114  Teratogen
0,070  0,022  Postcoital contraceptive
0,200  0,154  CYP1A2 substrate
0,096  0,050  Antineoplastic alkaloid
0,076  0,030  Glutamate (mGluR6) antagonist
0,194  0,148  CYP2D6 substrate
0,095  0,052  Restless leg syndrome treatment
0,096  0,054  Paget's disease treatment
0,062  0,022  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,084  0,043  Estrogen receptor alpha antagonist
0,139  0,100  Uterine stimulant
0,119  0,081  Antihyperlipoproteinemic
0,151  0,113  Antiviral (Influenza)
0,088  0,052  Hematopoietic
0,079  0,044  Antitreponemal
0,052  0,017  Progesterone antagonist
0,049  0,017  Hypogonadism treatment
0,151  0,119  Embryotoxic
0,093  0,061  ABCA1 expression enhancer
0,103  0,073  Mucolytic
0,099  0,070  Expectorant
0,090  0,064  SULT1E1 substrate
0,083  0,057  T cell inhibitor
0,083  0,058  Antiviral (Trachoma)
0,040  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,049  0,024  Opioid kappa receptor agonist
0,038  0,017  Tubulin agonist
0,169  0,148  Peptidyltransferase inhibitor
0,030  0,008  GRP78 expression inhibitor
0,038  0,017  RNA-directed RNA polymerase stimulant
0,196  0,176  Caspase 3 stimulant
0,042  0,022  5-Alpha-reductase inhibitor
0,102  0,084  Antiviral (Coronavirus)
0,102  0,084  Antiviral (SARS coronavirus)
0,023  0,005  Telomerase stimulant
0,053  0,037  Protein 50S ribosomal subunit inhibitor
0,121  0,105  SULT1A3 substrate
0,028  0,014  Protein 30S ribosomal subunit inhibitor
0,106  0,093  Alpha-N-acetylglucosaminidase inhibitor
0,029  0,015  Hedgehog signaling activator
0,018  0,005  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,119  0,106  Farnesoid X receptor antagonist
0,030  0,017  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,101  0,088  Interleukin 2 antagonist
0,025  0,012  Prostaglandin F2 alpha agonist
0,150  0,138  Antiparkinsonian, rigidity relieving
0,045  0,034  Microtubule stabilization
0,032  0,021  Liver X receptor antagonist
0,030  0,019  Liver X receptor alpha antagonist
0,017  0,007  Antibiotic Tetracycline-like
0,101  0,091  Autism spectrum disorders treatment
0,093  0,083  Toll-Like receptor 4 antagonist
0,044  0,035  Parathyroid hormone antagonist
0,175  0,167  Chemoprotective
0,024  0,020  Vanilloid 2 agonist
0,121  0,118  Prostatic (benign) hyperplasia treatment
0,028  0,025  Prostaglandin D2 agonist
0,121  0,119  Muscle relaxant
0,090  0,087  mTOR complex 1 inhibitor
0,112  0,110  Vanilloid 1 agonist
0,005  0,004  Transcortin receptor antagonist
0,035  0,034  Glucose-6-phosphate dehydrogenase inhibitor
0,101  0,100  Shock treatment

